Document is current
Any future updates will be listed below
-
Authors
Harvey, Nicholas C. https://orcid.org/0000-0002-8194-2512
Al-Daghri, Nasser https://orcid.org/0000-0001-5472-1725
Beaudart, Charlotte https://orcid.org/0000-0002-0827-5303
Brandi, Maria Luisa https://orcid.org/0000-0002-8741-0592
Burlet, Nansa
Campusano, Claudia https://orcid.org/0000-0001-5483-9301
Cavalier, Etienne
Chandran, Manju
Cooper, Cyrus https://orcid.org/0000-0003-3510-0709
Dawson-Hughes, Bess
Halbout, Philippe
Hough, Teréza
Lazaretti-Castro, Marise
Matijevic, Radmila https://orcid.org/0000-0002-4993-9399
Mithal, Ambrish https://orcid.org/0000-0002-0822-3212
Njeze, Ngozi https://orcid.org/0000-0003-2400-835X
Rizzoli, René https://orcid.org/0000-0002-1537-422X
Saleh, Yousef
Kanis, John A. https://orcid.org/0000-0002-3129-4326
Ward, Kate https://orcid.org/0000-0001-7034-6750
McCloskey, Eugene https://orcid.org/0000-0003-0177-8140
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 10 July 2025
First Online: 22 August 2025
Declarations
:
: This Position Paper article contains no original data and thus issues of ethics, informed consent and patient confidentiality do not apply.
: NC Harvey reports personal fees, consultancy, lecture fees and/or honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, UCB, Kyowa Kirin, Servier, Shire, Echolight, Consilient Healthcare, Theramex and Internis Pharma outside the submitted work. ML Brandi reports honoraria: Amgen, Ascendis, Bruno Farmaceutici, Calcilytix, Kyowa Kirin; Grants and/or speaker: Alexion, Amgen, Amolyt, Bruno Farmaceutici, CoGeDi, Echolight, Gedeon Richter, Kyowa Kirin, Monte Rosa Therapeutics, UCB; Consultant: Aboca, Alexion, Amolyt, Bruno Farmaceutici, Calcilytix, Echolight, Enterabio, Kyowa Kirin, Personal Genomics, Septerna. C Campusano reports lecture fees and/or honoraria from Faes farma, Novartis, Sandoz, Asofarma. M Chandran reports honoraria and consulting fees from Amgen Asia, Promedius. C Cooper reports personal fees, consultancy, lecture fees and/or honoraria from ABBH, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier and Takeda. M Lazaretti reports consultancy and lecture fees from Theramex, Sandoz, Astrazeneca, Mantecorp and Myralis. J Kanis is a director of Osteoporosis Research Ltd which maintains FRAX. E McCloskey reports personal fees, consultancy, lecture fees and/or honoraria from Amgen, Fresenius Kabi, Theramex, UCB. Director, Osteoporosis Research Ltd. N Al-Daghri, C Beaudart, N Burlet, E Cavalier, B Dawson-Hughes, P Halbout, T Hough, R Matijevic, A Mithal, N Njeze, R Rizzoli, Y Saleh, K Ward report no disclosures.
